U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07360145) titled 'Intelligent Support for Radiological Reporting of Lung Neoplasms' on Jan. 14.
Brief Summary: Lung cancer is one of the most common cancers and has one of the worst prognoses, mainly due to the difficulty of early diagnosis. In Italy, there are an estimated 41,000 new cases each year, and in 2021, the disease was responsible for approximately 34,000 deaths. The social impact is significant, as the disease is often diagnosed at an advanced stage, when the chances of survival are reduced: the 5-year survival rate is around 18% in advanced stages, while it can reach 90% if diagnosed at an early stage.
Early-stage lung cancer mainly man...